Navigation Links
A cure for honey bee colony collapse?
Date:4/14/2009

For the first time, scientists have isolated the parasite Nosema ceranae (Microsporidia) from professional apiaries suffering from honey bee colony depopulation syndrome. They then went on to treat the infection with complete success.

In a study published in the new journal from the Society for Applied Microbiology: Environmental Microbiology Reports, scientists from Spain analysed two apiaries and found evidence of honey bee colony depopulation syndrome (also known as colony collapse disorder in the USA). They found no evidence of any other cause of the disease (such as the Varroa destructor, IAPV or pesticides), other than infection with Nosema ceranae. The researchers then treated the infected surviving under-populated colonies with the antibiotic drug, flumagillin and demonstrated complete recovery of all infected colonies.

The loss of honey bees could have an enormous horticultural and economic impact worldwide. Honeybees are important pollinators of crops, fruit and wild flowers and are indispensable for a sustainable and profitable agriculture as well as for the maintenance of the non-agricultural ecosystem. Honeybees are attacked by numerous pathogens including viruses, bacteria, fungi and parasites. For most of these diseases, the molecular pathogenesis is poorly understood, hampering the development of new ways to prevent and combat honeybee diseases. So, any progress made in identifying causes and subsequent treatments of honey bee colony collapse is invaluable. There have been other hypothesis for colony collapse in Europe and the USA, but never has this bug been identified as the primary cause in professional apiaries.

"Now that we know one strain of parasite that could be responsible, we can look for signs of infection and treat any infected colonies before the infection spreads" said Dr Higes, principle researcher.

This finding could help prevent the continual decline in honey bee population which has recently been seen in Europe and the USA.


'/>"/>

Contact: Lucy Collister
lcollister@wiley.com
44-018-654-76241
Wiley-Blackwell
Source:Eurekalert

Related biology news :

1. Flight of the bumble (and honey) bee
2. Honeybees succumb to cocaines allure
3. Honey bees on cocaine dance more, changing ideas about the insect brain
4. Honeybees as plant bodyguards
5. Honey adds health benefits, is natural preservative and sweetener in salad dressings
6. Researchers discover that growing up too fast may mean dying young in honey bees
7. Pesticide build-up could lead to poor honey bee health
8. Honeybee researcher to unravel properties governing lifespan with support from Norway
9. Haagen-Dazs gift to support Penn State honeybee research
10. For honey bee queens, multiple mating makes a difference
11. Caste in the colony
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... and PORTLAND, Ore. , Feb. 22, ... Avamere Family of Companies (Avamere Health Services, Infinity Rehab, ... six-month research study that will apply the power of ... senior living and health centers. By analyzing data streaming ... gain insights into physical and environmental conditions, and obtain ...
(Date:2/14/2017)... 2017  Wake Forest Baptist Medical Center today announced Julie ... executive officer (CEO). Freischlag joins the medical center on ... , M.D., who last year announced that he would ... after leading it since 2008.   As ... Forest Baptist,s academic health system, which includes Wake Forest ...
(Date:2/10/2017)... 2017 Research and Markets has ... Medicine - Scientific and Commercial Aspects" to their offering. ... ... integrated with therapy for selection of treatment as well for ... prevention of disease in modern medicine. Biochip/microarray technologies and next ...
Breaking Biology News(10 mins):
(Date:3/29/2017)... and PETACH TIKVAH, ... -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a ... for neurodegenerative diseases, announced financial results for ... "2016 was a highly successful and ... achievements and significant progress made on clinical, ...
(Date:3/29/2017)... , March 29, 2017  Halozyme Therapeutics, Inc. ... and drug-delivery therapies, today announced that an Oncologic ... Drug Administration voted 11 to 0 that the ... injection was favorable for patients in the proposed ... and chronic lymphocytic leukemia. The FDA action date ...
(Date:3/29/2017)... CT (PRWEB) , ... March 29, 2017 , ... Bactana ... and hormones in the world’s food supply through enhancement of the gut microbiota, today ... round included Connecticut Innovations , New York-based Sustainable Income Capital Management, LLC and ...
(Date:3/29/2017)... March 29, 2017 /PRNewswire/ -  GeneNews Limited (TSX:GEN) ("GeneNews" ... , a new risk stratification test for breast cancer, via ... Diagnostics Laboratory ("IDL"). BreastSentry incorporates a blood-based biomarker test with ... risk for developing breast cancer.   ... BreastSentry measures the fasting plasma ...
Breaking Biology Technology: